As part of the collaboration, Lilly and Revvity will jointly fund access for selected participants, including access to Signals One and Signals Xynthetica software offerings and modeling credits. This ...
WALTHAM, Mass.--(BUSINESS WIRE)-- Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals, is unveiling the Signals ClinicalTM solution, a software-as-a ...
WALTHAM, Mass.--(BUSINESS WIRE)-- Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals, will launch Signals SynergyTM, a software solution designed ...
WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals Software, is introducing the new Signals ChemDraw ® offering, ...
Revvity, Inc. RVTY recently introduced Signals Xynthetica, a next-generation AI-augmented design platform aimed at transforming molecular and materials discovery across scientific industries.
Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals Software, will launch its Signals One(TM), a unified software platform evolved from the Company's existing ...
Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions ACD/Labs brings deep expertise in supporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback